Bringing Together Deep Bioscience and AI to Help Patients Worldwide: Novartis and Microsoft Work to Reinvent Treatment Discovery and Development
Oracle News, October 1st, 2019
October 1, 2019,
Volume 259, Issue 1

In the world of commercial research and science, there's probably no undertaking more daunting - or more expensive - than the process of bringing a new medicine to marke

"For a new compound to make it from initial discovery through development, testing and clinical trials to finally earn regulatory approval can take a decade or more. Nine out of 10 promising drug candidates fail somewhere along the way. As a result, on average, it costs life sciences companies $2.6 billion to introduce a single new prescription drug.

This is much more than just a challenge for life sciences companies. Streamlining drug development is an urgent issue for human health more broadly. From uncovering new ways to treat age-old sicknesses like malaria that still kills hundreds of thousands of people every year, to finding new cancer treatments, or developing new vaccines to prevent highly-contagious diseases from turning into global pandemics, the impact in terms of lives saved worldwide would be enormous if we could make inventing new medicines faster..."

Read More ...


Other articles in the Microsoft News section of Volume 259, Issue 1:

See all archived articles in the Microsoft News section.